$CGEN
Compugen Ltd
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.48
▲+0.81%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCompugen Ltd
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGEN up today? It is at $2.48 (+0.81%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGEN spikes, and full due diligence on CGEN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CGEN 5 times in the last 30 days. Create a free account to track $CGEN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mahler Michelle Officer | Acquired (grant/award) | +14K 0.01% of company | added 58% | 37K | n/a | Jul 29, 26 |
Zweifach Sanford S Director | Acquired (grant/award) | +8K | added 59% | 20K | n/a | Jul 29, 26 |
Halevy Gilead Director | Acquired (grant/award) | +8K | added 66% | 19K | n/a | Jul 29, 26 |
Hukkelhoven Mathias Director | Acquired (grant/award) | +8K | added 75% | 18K | n/a | Jul 29, 26 |
Livnat Savitzky Kinneret Director | Acquired (grant/award) | +8K | added 56% | 21K | n/a | Jul 29, 26 |
Kredo Russo Sharon Officer | Acquired (grant/award) | +18K 0.02% of company | added 92% | 38K | n/a | Jul 29, 26 |
Perry Eran Director | Acquired (grant/award) | +8K | added 75% | 18K | n/a | Jul 29, 26 |
Silberman David Officer | Acquired (grant/award) | +20K 0.02% of company | added 55% | 55K | n/a | Jul 29, 26 |
Levine Zurit Officer | Acquired (grant/award) | +18K 0.02% of company | added 61% | 47K | n/a | Jul 29, 26 |
Levine Zurit Officer | Sold (automatic/other) | -2K | sold 6.0% | 29K | $5K at $2.50 | Jul 9, 26 |
Levine Zurit Officer | Other | 2K | added 6.4% | 31K | $2K at $0.830 | Jul 9, 26 |
Ophir Eran Officer | Sold (automatic/other) | -5K | sold 31% | 11K | $16K at $3.20 | Apr 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CGEN last traded at $2.48, up 0.81% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Compugen Ltd (CGEN) is next expected to report earnings on Monday, November 9, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CGEN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGEN 5 times in the last 30 days.
CGEN (Compugen Ltd) trades on XNAS, with a market cap of about $236M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGEN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CGEN discussion
Sign in to ask a question or join the discussion.